Heart Test Laboratories, Inc. License Agreements
12 Contracts & Agreements
- License: Electrocardiogram Deep Learning Interpretability Toolbox (Filed With SEC on September 21, 2023)
- License: Diagnosis of STEMI using a model derived from a foundational vision transformer (HeartBEiT) (Filed With SEC on September 21, 2023)
- License: Diagnosis of Hypertrophic Cardiomyopathy using a model derived from a foundational vision transformer (HeartBEiT) (Filed With SEC on September 21, 2023)
- License: Derivation of low Left Ventricular Ejection fraction based on a foundational vision transformer (HeartBEiT) (Filed With SEC on September 21, 2023)
- License: Deep learning for electrocardiograms to identify left heart valvular dysfunction mitral regurgitation (Filed With SEC on September 21, 2023)
- License: Deep learning for electrocardiograms to identify left heart valvular dysfunction - aortic stenosis (Filed With SEC on September 21, 2023)
- License: Prediction of right ventricular size and systolic function from the 12-lead ECG (Filed With SEC on September 21, 2023)
- License: Deep Learning on ECGs to Derive Left and Right Ventricular Function (Filed With SEC on September 21, 2023)
- License: Deep Learning Algorithm to Predict PVC-Related Cardiomyopathy (Filed With SEC on September 21, 2023)
- License: Pulmonary Embolism Detection From the Electrocardiogram Using Deep Learning (Filed With SEC on September 21, 2023)
- Amendment No. 2 License Agreement by and between Heart Test Laboratories, Inc. and The University Court of The University of Glasgow, dated March 31, 2023 (Filed With SEC on July 19, 2023)
- Evaluation, Option and License Agreement by and between Heart Test Laboratories, Inc. and The University Court of The University of Glasgow, dated June 2, 2015 (Filed With SEC on May 17, 2022)
